A Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Participants

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKenvue Brands LLC

About this trial

The study aims to evaluate the efficacy of a facial sunscreen under two experimental conditions-untinted and tinted-in improving facial spots (melasma and solar lentigines/post-inflammatory hyperpigmentation) after 8 weeks of product use under normal conditions by adult participants.

Eligibility criteria

Qualifiers

Able to understand and follow study instructions

Fitzpatrick skin types I-VI

Mild to moderate melasma, or

Visible dark spots (e.g., solar lentigines or post-inflammatory hyperpigmentation)

Disqualifiers

Known sensitivity or allergy to cosmetic or skincare products

Skin conditions or lesions in the study area that could interfere with evaluation (e.g., active dermatitis, infections, significant irritation, or extensive scarring)

Use of medications or products that may interfere with study evaluations

Recent cosmetic or dermatological procedures in the study area (e.g., chemical peels, laser treatments, invasive procedures)

Trial design

Treatments tested in this trial

  • Sunscreen untinted
  • Sunscreen tinted

Treatment groups

152 Participants
are divided into 4 treatment groups

Sponsors and collaborators